{"id":7977,"date":"2019-10-30T12:04:18","date_gmt":"2019-10-30T16:04:18","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/major-win-for-dangerous-drug-victims\/"},"modified":"2019-10-30T12:04:18","modified_gmt":"2019-10-30T16:04:18","slug":"major-win-for-dangerous-drug-victims","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/en\/article\/major-win-for-dangerous-drug-victims\/","title":{"rendered":"Major Win for Dangerous Drug Victims"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">A Philadelphia jury ordered Johnson &amp; Johnson subsidiary Janssen Pharmaceuticals to pay <\/span><a href=\"https:\/\/www.bbc.com\/news\/business-49982237\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">$8 billion<\/span><\/a><span style=\"font-weight: 400;\"> in a drug-induced gynecomastia matter.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">26-year-old Nicholas Murray developed abnormally large breasts in 2003. He had been taking Risperdal, an antipsychotic drug, to control his autism spectrum disorder symptoms. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">In a statement, J&amp;J said it would appeal the \u201cgrossly disproportionate\u201d award. There are thousands of other <\/span><a href=\"\/practice-areas\/pharmaceutical-litigation\/\"><span style=\"font-weight: 400;\">Risperdal\/gynecomastia cases<\/span><\/a><span style=\"font-weight: 400;\"> pending in Pennsylvania and around the country.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Johnson &amp; Johnson faces a number of other legal woes as well. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">In August, an Oklahoma federal judge ordered the company to pay over $550 million as a penalty for its \u201cfalse and dangerous\u201d opioid painkiller sales campaign. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Victims of J&amp;J\u2019s asbestos-laced talcum powder products have obtained a number of favorable, multimillion-dollar verdicts as well.<\/span><\/p>\n<h3><b>Risperdal, Gynecomastia, and Potential Side-Effects<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Risperidone (Risperdal) is one of many medicines linked to <\/span><a href=\"https:\/\/www.pharmaco-vigilance.eu\/content\/drug-induced-gynecomastia\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">drug-induced gynecomastia<\/span><\/a><span style=\"font-weight: 400;\">. Risperdal is a second-generation, or atypical, antipsychotic. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">The Food and Drug Administration approved Risperdal for limited treatment of extreme schizophrenia patients. But as outlined below, doctors prescribe this drug for a number of other uses as well.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Atypical antipsychotics appeared in the 1990s as a response to typical antipsychotics. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Thorazine, Loxatane, and other antipsychotic drugs synthesized in the 1950s were relatively effective, but they had some rather nasty psychotic side-effects. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Risperdal and its ilk essentially block serotonin receptors in the brain, thus increasing the amount of dopamine. The hormonal imbalance affects the body as well as the brain.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Pregnancy hormones cause womens\u2019 breasts to change, and artificial hormones also cause men\u2019s breasts to change. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Gynecomastia side-effects include intense chest pain and a <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2276281\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">500 percent increased risk of breast cancer<\/span><\/a><span style=\"font-weight: 400;\">. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">This condition also has profound social and emotional effects, especially on younger men and boys.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Almost as soon as the drug hit the market, both the FDA and Johnson &amp; Johnson began fielding reports about the link between Risperdal overuse and gynecomastia.<\/span><\/p>\n<p><span style=\"font-weight: 400;\"> Yet J&amp;J refused to pull Risperdal off the shelves or even issue stronger warnings.\u00a0<\/span><\/p>\n<h3><b>Off-Label Use<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Manufacturers only issue warnings or recall products in extreme circumstances. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">The economic pressures are just too great.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">According to some estimates, the cost to bring a new drug to market may be <\/span><a href=\"https:\/\/www.policymed.com\/2014\/12\/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de.html\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">over $2.5 billion<\/span><\/a><span style=\"font-weight: 400;\">. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Manufacturers like Johnson &amp; Johnson must sell a lot of pills in a very short amount of time to recoup these costs and show a healthy profit. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">After just a few years, less-expensive generic equivalents become available, so demand drops for the pricey original.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">As a result, manufacturers do not just avoid actions, like stern warning labels, which may limit product sales. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">They often encourage doctors to use pharmaceutical products in ways that the FDA has not technically approved.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Risperdal is a good example. Since it is a serotonin blocker, doctors prescribed it for a wide range of mental disorders. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Note that doctors diagnosed the victim in the above case with autism spectrum disorder, a condition which is normally not severe and often barely noticeable. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">So, victims took this powerful, hormone-altering drug when something weaker probably would have sufficed.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Do you see where we\u2019re going with this? Risperdal usually does not cause gynecomastia unless it is overused. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">That\u2019s exactly what happened in this instance.<\/span><\/p>\n<h3><b>Your Claim for Damages<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Legally, manufacturers like Johnson &amp; Johnson are strictly liable for the damages their defective products cause. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">In New York, it is easier to establish this causal link than in some other states. New York courts use a more relaxed, victim-friendly standard to evaluate doctors and other expert witnesses.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Juries make stratospheric damage awards in some of these cases because of punitive damages. Negligence, or lack thereof, is not relevant when it comes to the victim\u2019s economic injuries, like medical bills, or noneconomic injuries, like pain and suffering. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">But negligence, and recklessness in this case, is relevant on the question of punitive damages. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">If the company clearly put profits before people, jurors usually respond accordingly.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Admittedly, a higher court will probably reduce this amount on appeal. But even if the damage award is cut in half, $4 billion is still an awful lot of money.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Procedurally, dangerous drug claims often go to central locations for pretrial purposes. Multidistrict Litigation greatly benefits plaintiffs. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">The victims pool their resources against the pharmaceutical company. And, when one case settles, it often triggers a domino effect. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">If a particular case does not settle out of court, it usually goes back to its home jurisdiction for trial.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The catch in all this is that an attorney must have substantial resources, and substantial experience, to obtain maximum compensation in dangerous drug cases. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">At Napoli Shkolnik , our <\/span><a href=\"\/contact-us\/\"><span style=\"font-weight: 400;\">experienced New York personal injury attorneys<\/span><\/a><span style=\"font-weight: 400;\"> have those credentials. Contact us now for a free consultation.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Philadelphia jury ordered Johnson &amp; Johnson subsidiary Janssen Pharmaceuticals to pay $8 billion in a drug-induced gynecomastia matter.\u00a0 26-year-old Nicholas Murray developed abnormally large breasts in 2003. He had&#8230;<\/p>\n","protected":false},"author":3,"featured_media":7978,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[776],"tags":[917,918,975,976],"class_list":["post-7977","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-litigation","tag-pharmaceutical-lawsuit","tag-pharmaceutical-lawyers","tag-risperdal","tag-gynecomastia"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/posts\/7977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/comments?post=7977"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/posts\/7977\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/media\/7978"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/media?parent=7977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/categories?post=7977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/tags?post=7977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}